Related Experiment Video
Updated: May 10, 2026

Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation
Published on: October 15, 2021
Intracerebral hemorrhage: new challenges and steps forward
Jose Javier Provencio1, Ivan Rocha Ferreira Da Silva, Edward Michael Manno
1Cerebrovascular Center, S80, Cleveland Clinic, 9500 Euclid Avenue Cleveland, OH 44195, USA. provenj@ccf.org
Insights
Intracerebral hemorrhage (ICH) incidence is rising due to an aging population and anticoagulant use. New preventative and treatment strategies are crucial for managing this neurological emergency.
Area of Science:
- Neurology
- Public Health
- Vascular Medicine
Background:
- Intracerebral hemorrhage (ICH) is a major cause of death and disability.
- Rising incidence is projected due to demographic shifts and increased anticoagulant use.
- Current preventative strategies for hypertension and atrial fibrillation require enhancement.
Purpose of the Study:
- To review the epidemiology, pathophysiology, and current treatments for ICH.
- To analyze treatment and outcome variations in patients on anticoagulant therapy.
- To highlight the need for advanced preventative and therapeutic approaches.
Main Methods:
- Literature review of epidemiological data.
- Discussion of pathophysiological mechanisms at vascular and molecular levels.
- Analysis of current clinical management and treatment options.
Main Results:
- ICH incidence is increasing, particularly in aging populations and those using anticoagulants.
- Hypertension and atrial fibrillation are key modifiable risk factors.
- Understanding ICH pathophysiology may lead to novel therapeutic targets.
Conclusions:
- Urgent improvements in hypertension and atrial fibrillation management are needed.
- Advances in understanding ICH offer potential for new treatments.
- Tailored treatment strategies considering anticoagulant use are essential for better outcomes.
Abstract:
Intracerebral hemorrhage (ICH) is a significant cause of morbidity and mortality. With the aging population, increased use of anticoagulants, and changing racial and ethnic landscape of the United States, the incidence of ICH will increase over the next decade. Improvements in preventative strategies to treat hypertension and atrial fibrillation are necessary to change the trajectory of this increase. Advances in the understanding of ICH at the vascular and molecular level may pave the way to new treatment options. This article discusses the epidemiology, pathophysiology, and current treatment options for patients with ICH. Differences in outcome and treatment between patients taking and not taking anticoagulant therapies are considered.
Related Concept Videos
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Cerebral Edema ll: Pathophysiology
Ischemic Stroke ll: Pathophysiology
Increased Intracranial Pressure l: Introduction
Increased Intracranial Pressure ll: Pathophysiology

